Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Arch closes $3B-plus fund to foster biopharma upstarts
On the heels of Bain's $3 billion fund, Arch Venture Partners has closed a VC fund of "more than $3 billion."
Fraiser Kansteiner
Sep 26, 2024 10:24am
A VC recovery may be coming in Europe: PitchBook
Aug 22, 2024 3:00pm
Element Biosciences nets $277M ahead of new sequencer launch
Jul 11, 2024 2:00pm
Zenas bags $200M series C to reach a handful of key mAB readouts
May 7, 2024 7:00am
Sofinnova opens biotech creation ‘toolbox’ for Europe strategy
Dec 13, 2023 9:20am
Fosun, Treehill join forces to invest in drugs angling for US
Nov 20, 2023 6:30am
